Clinical Trial Update: Long-term Safety and Tolerability of BHV-7000 [Phase 2]

View source ↗

Summary

This clinical trial update describes the ongoing Phase 2 assessment of BHV-7000 for focal epilepsy, focusing on long-term safety and tolerability. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Drugs mentioned

• BHV-7000

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Focal Epilepsy | Phase 2 | Status: ENROLLING_BY_INVITATION